Aurora Cannabis (ACB) Reports Q4 Revenue of C$72.1 Million

Aurora Cannabis (NYSE: ACB) reported Q4 revenue of Cdn$72.1 million, a 5% decrease from the prior quarter.

• Adjusted EBITDA1 in Q4 2020 was a loss of $34.6 million, an improvement of $15.8 million from the prior quarter Adjusted EBITDA loss of $50.4 million. Excluding severance costs, R&D termination costs and divested business results, Q4 Adjusted EBITDA was a loss of $30.7 million.

Guidance:

Following the divestiture of non-core subsidiaries during fiscal 2020, net revenue in Q1 2021 is expected to be comprised exclusively of cannabis net revenue. Cannabis net revenue is expected to be between $60 million and $64 million, compared to $67.5 million in Q4 2020. The Company expects adjusted gross margin before fair value adjustments on cannabis net revenue to be within a range of 46%-50% and SG&A costs (including R&D) in the low $40 million range.

For earnings history and earnings-related data on Aurora Cannabis (ACB) click here.

You May Also Be Interested In

• Korn Ferry (KFY) Tops Q4 EPS by 2c, Beats on Revenue; Offers Q1 Guidance
• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• AeroVironment restates quarterly financials, citing $89M goodwill error